Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.52 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 4/20 | 0.50 |
| ▸ | MMP9 | P14780 | 3/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 2/20 | 0.49 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.48 |
| ▸ | ACE | P12821 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL286032 | 1.00 | MEN1 (0.63) | MEN1KMT2AL3MBTL1CA1CA2 | |
| Chloroform SCHEMBL28104113 | 0.95 | MEN1 (0.59) | MEN1KMT2AL3MBTL1CA1CA2 | |
| SCHEMBL7297540 | 0.86 | MMP2 (0.65) | CA1CA2NAALAD2MMP2MMP9 | |
| SCHEMBL7297543 | 0.86 | MMP2 (0.65) | CA1CA2NAALAD2MMP2MMP9 | |
| SCHEMBL17318156 | 0.85 | L3MBTL1 (0.62) | MEN1KMT2AL3MBTL1CA1CA2 | |
| SCHEMBL17318080 | 0.85 | L3MBTL1 (0.62) | MEN1KMT2AL3MBTL1CA1CA2 | |
| SCHEMBL3266667 | 0.84 | MEN1 (0.60) | MEN1KMT2AL3MBTL1CA1CA2 | |
| SCHEMBL28396545 | 0.84 | L3MBTL1 (0.64) | MEN1KMT2AL3MBTL1CA1CA2 | |
| SCHEMBL8912956 | 0.81 | L3MBTL1 (0.78) | MEN1KMT2AL3MBTL1MMP2MMP9 | |
| SCHEMBL17111996 | 0.81 | ITGB3 (0.49) | MEN1KMT2AL3MBTL1CA2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195327-A1 | METHOD FOR PREVENTING OR LIMITING PROGRESSION OF MYOPIA | CATALTHEIA GROUP, INC. (US) | 2025-06-19 | — | — | US | claimed |
| US-20210294125-A1 | SOFT CONTACT LENS | BF RESEARCH S.R.L. (IT) | 2021-09-23 | — | — | US | claimed |
| EP-3797333-A1 | SOFT CONTACT LENS | BF Research S.r.L. (IT) | 2021-03-31 | — | — | EP | claimed |
| CN-106146360-B | Method for preparing tyrosine-O-sulfonate | 深圳翰宇药业股份有限公司 | 2020-05-15 | — | — | CN | claimed |
| EP-3383883-A1 | SALTS OF CONJUGATES FOR CANCER THERAPY | BioSight Ltd. (IL) | 2018-10-10 | — | — | EP | claimed |
| WO-2017094011-A1 | SALTS OF CONJUGATES FOR CANCER THERAPY | BIOSIGHT LTD. (IL) | 2017-06-08 | — | — | WO | claimed |
| CN-106146360-A | A kind of method preparing tyrosine-O-sulfonate | 深圳翰宇药业股份有限公司 | 2016-11-23 | — | — | CN | claimed |
| EP-1411964-A4 | PEPTIDES WHICH MODULATE BLOOD COAGULATION AND METHODS OF USE THEREOF | OREGON HEALTH SCIENCE UNIVERSI (US) | 2006-06-14 | — | — | EP | claimed |
| US-20040248807-A1 | Peptides which modulate blood coagulation and methods of use thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-12-09 | — | — | US | claimed |
| EP-1411964-A2 | PEPTIDES WHICH MODULATE BLOOD COAGULATION AND METHODS OF USE THEREOF | OREGON HEALTH SCIENCE UNIVERSITY (US) | 2004-04-28 | — | — | EP | claimed |
| WO-2003003988-A2 | PEPTIDES WHICH MODULATE BLOOD COAGULATION AND METHODS OF USE THEREOF | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2003-01-16 | — | — | WO | claimed |
| US-20250195327-A1 | METHOD FOR PREVENTING OR LIMITING PROGRESSION OF MYOPIA | CATALTHEIA GROUP, INC. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20250145668-A1 | EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION | CENTIVAX, INC. | 2025-05-08 | — | — | US | disclosed |
| CN-116338052-B | High performance liquid chromatography analysis method for O-sulfo-L-tyrosine sodium salt and related substances thereof | 安徽盈科生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-12268652-B2 | Method for preventing or limiting progression of myopia | CATALTHEIA GROUP, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-6548636-B2 | Composition for use as viricide in prevention of viral infection | PROGENICS PHARMACEUTICALS, INC. | 2003-04-15 | — | — | US | disclosed |
| WO-2003003988-A2 | PEPTIDES WHICH MODULATE BLOOD COAGULATION AND METHODS OF USE THEREOF | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2003-01-16 | — | — | WO | disclosed |
| WO-2002068608-A2 | SULFATED CCR5 PEPTIDES FOR HIV-1 INFECTION | PROGENICS PHARMACEUTICALS, INC. (US) | 2002-09-06 | — | — | WO | disclosed |
| US-20020068813-A1 | Sulfated CCR5 peptides for HIV-1 infection | AARON DIAMOND AIDS RESEARCH CENTRE (ADARC) | 2002-06-06 | — | — | US | disclosed |
| WO-2001064710-A2 | SULFATED CCR5 PEPTIDES FOR HIV-1 INFECTION | PROGENICS PHARMACEUTICALS, INC. (US) | 2001-09-07 | — | — | WO | disclosed |